Replies to post #7189 on Revance Therapeutics Inc (RVNC)

[alertmeipp]

>>about 30% of their toxin use is Daxxify

That's very high percentage (I assume 15% for my base case), is it not?

[Emannow]

Thank you for your input and thoughts!

Two important points to consider: (1) if you look at the sales region award winners for RVNC and Allergan, you can see what areas of the country are doing well with Daxi and Botox. RVNC is doing very well in the Northeast and Mid Atlantic as well as a few other areas in the USA as these regions are winning sales awards every year. Allergan is doing well in the Northwest and Southwest USA as these areas are their sales award winners!

(2) KOLs are charging patients 50% to 75% more for Daxi versus Botox and purchasing Daxi for less than Botox. KOLs are all about the $$ and are now a very small % of total sales. National Med Spa chains and large multi unit practices make up over 50% of the Botox sales. KOLs write most of the white papers but do very little of the injections.

If KOLs charge patients a far price for Daxi as compared to the cost, 75% of their patients would pick Daxi. Eventually, competitive pricing for Daxi will impact the prices KOLs charge! Over time, patients will realize and understand the benefits of Daxi at a fair price.